UBS Maintains Buy on XP, Lowers Price Target to $25

Benzinga Newsdesk www.benzinga.com Negative 67.6%

Neg 67.6% Neu 0% Pos 0%

UBS analyst Thiago Batista maintains XP (NASDAQ:XP) with a Buy and lowers the price target from $28 to $25.

Comments

No comments yet. Be the first!